Doxecitine; Doxribtimine Patent Expiration
Doxecitine; Doxribtimine was first introduced by Ucb Inc
Doxecitine; Doxribtimine Patents
Given below is the list of patents protecting Doxecitine; Doxribtimine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Kygevvi | US11649259 | Polymorphic Forms Of Deoxycytidine, Compositions Comprising The Same And Uses | Aug 19, 2040 | Ucb Inc |
| Kygevvi | US10471087 | Deoxynucleoside Therapy For Diseases Caused By Unbalanced Nucleotide Pools Including Mitochondrial Dna Depletion Syndromes | Aug 07, 2036 | Ucb Inc |
Doxecitine; Doxribtimine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List